Sodium thiosulfate protects hearing after cisplatin treatment

M3 Global Newsdesk Aug 06, 2018

Delayed administration of sodium thiosulfate after cisplatin chemotherapy halves the risk of high-grade cisplatin-related hearing loss without adversely affecting outcomes in children with hepatoblastoma, reports an international team of researchers in The New England Journal of Medicine.


In a study of children between 1 month and 18 years of age, hearing loss of grade 1 or higher occurred in 33% of children randomized to cisplatin and sodium thiosulfate, compared with 63% randomized to...

Clinical Practice International Medicine Patient Research

Non loggedin lock

To read this article Sign up / Login for free

This article is only available to members. Are you a doctor? Click here to signup for free.